• 1. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 4. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 5. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549

• Catalysts and Inorganic Chemicals Inorganic Compounds Homogeneous non-metal compounds Homogeneous other non-metal compounds

Introduction to 6-Nitrobenzo[d]isoxazole-3-carbonitrile (CAS No. 343945-78-8)

6-Nitrobenzo[d]isoxazole-3-carbonitrile, identified by the Chemical Abstracts Service Number (CAS No.) 343945-78-8, is a specialized organic compound that has garnered significant attention in the field of medicinal chemistry and pharmaceutical research. This heterocyclic compound belongs to the benzo[d]isoxazole class, characterized by a benzene ring fused with an isoxazole ring system. The presence of a nitro group and a nitrile group at the 6-position and 3-position, respectively, imparts unique electronic and steric properties, making it a valuable scaffold for the development of novel bioactive molecules.

The structural motif of 6-Nitrobenzo[d]isoxazole-3-carbonitrile positions it as a promising candidate for further derivatization and exploration in drug discovery programs. Its molecular framework combines the aromatic stability of the benzene ring with the bioisosteric potential of the isoxazole core, which is frequently observed in biologically active compounds. The nitro group, a well-documented pharmacophore, can modulate electronic properties and influence interactions with biological targets, while the nitrile group introduces polarity and potential hydrogen bonding capabilities.

In recent years, there has been growing interest in benzo[d]isoxazole derivatives due to their demonstrated efficacy in various therapeutic areas, including anti-inflammatory, anticancer, and antimicrobial applications. The nitrobenzo[d]isoxazole scaffold has been extensively studied for its ability to interact with enzymes and receptors involved in disease pathways. For instance, modifications at the 3-position of this scaffold have been shown to enhance binding affinity to specific protein targets, suggesting its utility in designing targeted therapies.

One of the most compelling aspects of 6-Nitrobenzo[d]isoxazole-3-carbonitrile is its versatility as a building block for medicinal chemistry. Researchers have leveraged its core structure to develop libraries of compounds with tailored pharmacological profiles. The nitrile group, in particular, has been exploited for its role as a prodrug moiety or for enhancing metabolic stability. Additionally, the electron-withdrawing nature of both the nitro and nitrile groups can fine-tune physicochemical properties such as solubility and lipophilicity, which are critical factors in drug formulation and delivery.

Recent advances in computational chemistry have further accelerated the exploration of 6-Nitrobenzo[d]isoxazole-3-carbonitrile derivatives. Molecular modeling studies have revealed insights into how structural modifications influence binding interactions with biological targets. These simulations have guided synthetic strategies aimed at optimizing potency and selectivity. For example, virtual screening campaigns have identified novel analogs with improved pharmacokinetic profiles, highlighting the potential of this scaffold in addressing unmet medical needs.

The synthesis of 6-Nitrobenzo[d]isoxazole-3-carbonitrile involves multi-step organic transformations that require precise control over reaction conditions. Key synthetic routes typically involve condensation reactions between appropriately substituted benzene derivatives and oxazolidinones or hydroxamic acids under acidic or basic catalysis. The introduction of the nitro group is often achieved through electrophilic aromatic substitution reactions, while cyanation can be accomplished via nucleophilic addition or metal-catalyzed processes.

In terms of biological activity, preliminary studies on 6-Nitrobenzo[d]isoxazole-3-carbonitrile have shown promising results in vitro. Its derivatives have demonstrated inhibitory effects against enzymes implicated in inflammatory responses and cancer progression. The nitro group has been particularly noted for its ability to modulate redox-sensitive signaling pathways, which are relevant in diseases such as neurodegeneration and autoimmune disorders. Furthermore, structural analogs have exhibited antimicrobial properties against resistant strains of bacteria, underscoring the broad therapeutic potential of this class of compounds.

The integration of 6-Nitrobenzo[d]isoxazole-3-carbonitrile into drug discovery pipelines aligns with current trends toward rational drug design and targeted therapy. By leveraging structural scaffolds like this one, researchers can efficiently generate compounds with optimized interactions across multiple biological targets. This approach not only accelerates the development process but also reduces attrition rates associated with traditional high-throughput screening methods.

Future directions for research on 6-Nitrobenzo[d]isoxazole-3-carbonitrile include exploring its role in modulating central nervous system (CNS) disorders. The benzo[d]isoxazole core is known to penetrate the blood-brain barrier under certain conditions, making it an attractive scaffold for neuropharmacological applications. Additionally, investigating its metabolic fate and toxicological profile will be crucial for advancing preclinical candidates toward clinical trials.

Overall,6-Nitrobenzo[d]isoxazole-3-carbonitrile (CAS No. 343945-78-8) represents a significant asset in medicinal chemistry research due to its structural versatility and demonstrated biological relevance. As synthetic methodologies continue to evolve and computational tools become more sophisticated，this compound is poised to play an integral role in developing next-generation therapeutics across diverse disease indications.

• 66639-59-6(Benzonitrile, 4-(5-nitro-1,2-benzisoxazol-3-yl)-)
• 343868-60-0(6-Aminobenzo[d]isoxazole-3-carbonitrile)
• 66048-16-6(1,2-Benzisoxazole, 3-ethyl-5-nitro-)
• 37924-88-2(1,2-Benzisoxazole, 3-(bromomethyl)-5-nitro-)
• 63770-49-0(1,2-BENZISOXAZOLE, 3,5-DIMETHYL-7-NITRO-)
• 63770-51-4(1,2-BENZISOXAZOLE, 3,6-DIMETHYL-5-NITRO-)
• 102741-53-7(1,2-Benzisoxazole-3-acetonitrile, 6-nitro-)
• 102741-52-6(1,2-Benzisoxazole-3-methanol,6-nitro-)
• 642087-62-5(1,2-Benzisoxazole-3-ethanol,5-nitro-)
• 63770-48-9(3-Methyl-5-nitrobenzodisoxazole)